{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:03:27Z","timestamp":1792253007246,"version":"4.4.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Multiple myeloma (MM) is a plasma cell neoplasm that depends on the bone marrow (BM) microenvironment; however, the underlying mechanisms of epigenetic contribution to the pathogenesis of MM are incompletely understood. Here, we delineate epigenetically driven transcriptional and splicing regulation crucial for MM. We recharacterized the transcriptional program induced by interleukin 6 (IL-6)\/Janus kinase (JAK)\/signal transducer and activator of transcription 3 (STAT3) pathway by integrating chromatin immunoprecipitation sequencing, transcriptomic analyses, and CRISPR knockout screening, identifying the B-cell lineage factors POU2AF1 and ELL2, as crucial IL-6\/JAK\/STAT3 targets essential for MM cell growth and survival. Genetic depletion of these factors significantly suppressed MM cell growth in vitro and in the xenograft model of IL-6 humanized mice. Mechanistically, POU2AF1 and ELL2 form an autoregulatory loop with IRF4 and establish an MM-distinct transcriptional program representing cellular immaturity. The IL-6\/JAK\/STAT3 pathway augments this program by upregulating and recruiting these factors to MM signature genes. Furthermore, POU2AF1 and ELL2 are essential in the regulation of IL-6\u2013dependent alternative RNA splicing. Immunocytochemical and proteomic analyses revealed that POU2AF1 colocalizes and facilitates formation of nuclear speckles, where it interacts with trans-acting splicing factors required for MM cell growth. These findings suggest dual roles of POU2AF1 and ELL2 in coordinating transcription and RNA splicing to generate MM-associated mRNA isoforms. Finally, we showed that gapmer antisense oligonucleotides targeting POU2AF1 reduced MM cell growth in the presence of soluble BM stromal cell factors, including IL-6. Our data demonstrate that IL-6\u2013driven B-cell lineage factors are the vulnerability of MM cells and may represent novel therapeutic targets for this incurable tumor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018710","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:53:45Z","timestamp":1775138025000},"page":"4049-4066","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["IL-6\u2013driven POU2AF1 and ELL2 are key regulators of multiple myeloma\u2013distinct transcriptional and splicing programs"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1733-8515","authenticated-orcid":false,"given":"Yasuyo","family":"Ohguchi","sequence":"first","affiliation":[{"name":"1Division of Disease Epigenetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-4788","authenticated-orcid":false,"given":"Masahiko","family":"Ajiro","sequence":"additional","affiliation":[{"name":"2Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1946-8609","authenticated-orcid":false,"given":"Daisuke","family":"Ogiya","sequence":"additional","affiliation":[{"name":"3Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-4783","authenticated-orcid":false,"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[{"name":"4Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8269-440X","authenticated-orcid":false,"given":"Yawara","family":"Kawano","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-3322","authenticated-orcid":false,"given":"Shingo","family":"Usuki","sequence":"additional","affiliation":[{"name":"6Liaison Laboratory Research Promotion Center, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9584-2611","authenticated-orcid":false,"given":"Tomoaki","family":"Koga","sequence":"additional","affiliation":[{"name":"7Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-016X","authenticated-orcid":false,"given":"Shinjiro","family":"Hino","sequence":"additional","affiliation":[{"name":"7Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3997-7471","authenticated-orcid":false,"given":"Takeshi","family":"Harada","sequence":"additional","affiliation":[{"name":"8Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-7760","authenticated-orcid":false,"given":"Satoru","family":"Takahashi","sequence":"additional","affiliation":[{"name":"9Department of Anatomy and Embryology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3124-5206","authenticated-orcid":false,"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[{"name":"10Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-2080","authenticated-orcid":false,"given":"Jun-ichirou","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2318-5987","authenticated-orcid":false,"given":"Goro","family":"Sashida","sequence":"additional","affiliation":[{"name":"11Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-7133","authenticated-orcid":false,"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[{"name":"12Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-8673","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Nakao","sequence":"additional","affiliation":[{"name":"7Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-1379","authenticated-orcid":false,"given":"Takashi","family":"Minami","sequence":"additional","affiliation":[{"name":"13Division of Molecular and Vascular Biology, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-7281","authenticated-orcid":false,"given":"Akihide","family":"Yoshimi","sequence":"additional","affiliation":[{"name":"2Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8461-7398","authenticated-orcid":false,"given":"Hiroto","family":"Ohguchi","sequence":"additional","affiliation":[{"name":"1Division of Disease Epigenetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026060911322616100_bib1","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"6092","key":"2026060911322616100_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/324073a0","article-title":"Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin","volume":"324","author":"Hirano","year":"1986","journal-title":"Nature"},{"issue":"6159","key":"2026060911322616100_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/332083a0","article-title":"Autocrine generation and requirement of BSF-2\/IL-6 for human multiple myelomas","volume":"332","author":"Kawano","year":"1988","journal-title":"Nature"},{"issue":"2","key":"2026060911322616100_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V73.2.517.517","article-title":"Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6","volume":"73","author":"Klein","year":"1989","journal-title":"Blood"},{"issue":"1","key":"2026060911322616100_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1073\/pnas.89.1.232","article-title":"Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice","volume":"89","author":"Suematsu","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2026060911322616100_bib6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1073\/pnas.022643999","article-title":"IL-6 transgenic mouse model for extraosseous plasmacytoma","volume":"99","author":"Kovalchuk","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2026060911322616100_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.4202","article-title":"Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice","volume":"22","author":"Das","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"2026060911322616100_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404466","article-title":"Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma","volume":"21","author":"Arnulf","year":"2007","journal-title":"Leukemia"},{"issue":"6","key":"2026060911322616100_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","article-title":"The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape","volume":"22","author":"de Jong","year":"2021","journal-title":"Nat Immunol"},{"issue":"12","key":"2026060911322616100_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/17474086.2021.1983427","article-title":"Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies","volume":"14","author":"Bisht","year":"2021","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"2026060911322616100_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2004-01-0037","article-title":"Advances in biology of multiple myeloma: clinical applications","volume":"104","author":"Hideshima","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2026060911322616100_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2003-04-1048","article-title":"Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation","volume":"103","author":"Brocke-Heidrich","year":"2004","journal-title":"Blood"},{"issue":"6512","key":"2026060911322616100_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/373360a0","article-title":"A B-cell coactivator of octamer-binding transcription factors","volume":"373","author":"Gstaiger","year":"1995","journal-title":"Nature"},{"issue":"3","key":"2026060911322616100_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0092-8674(95)90500-6","article-title":"OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins","volume":"80","author":"Strubin","year":"1995","journal-title":"Cell"},{"issue":"8","key":"2026060911322616100_bib15","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/MCB.15.8.4115","article-title":"Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B","volume":"15","author":"Luo","year":"1995","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2026060911322616100_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2003.08.002","article-title":"OCA-B regulation of B-cell development and function","volume":"24","author":"Teitell","year":"2003","journal-title":"Trends Immunol"},{"issue":"17","key":"2026060911322616100_bib17","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1093\/emboj\/17.17.5066","article-title":"OCA-B integrates B cell antigen receptor-CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development","volume":"17","author":"Qin","year":"1998","journal-title":"EMBO J"},{"issue":"2","key":"2026060911322616100_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)64754-2","article-title":"Up-regulation of BOB.1\/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas","volume":"156","author":"Greiner","year":"2000","journal-title":"Am J Pathol"},{"issue":"6600","key":"2026060911322616100_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/383538a0","article-title":"B-cell-specific coactivator OBF-1\/OCA-B\/Bob1 required for immune response and germinal centre formation","volume":"383","author":"Schubart","year":"1996","journal-title":"Nature"},{"issue":"6600","key":"2026060911322616100_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/383542a0","article-title":"The B-cell-specific transcription coactivator OCA-B\/OBF-1\/Bob-1 is essential for normal production of immunoglobulin isotypes","volume":"383","author":"Kim","year":"1996","journal-title":"Nature"},{"issue":"12","key":"2026060911322616100_bib21","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1002\/eji.1830261255","article-title":"B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1\/OCA-B\/OBF1","volume":"26","author":"Nielsen","year":"1996","journal-title":"Eur J Immunol"},{"issue":"5","key":"2026060911322616100_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(02)00911-X","article-title":"OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes","volume":"110","author":"Casellas","year":"2002","journal-title":"Cell"},{"issue":"6","key":"2026060911322616100_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.onc.1209127","article-title":"Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression","volume":"25","author":"Heckman","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"2026060911322616100_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","article-title":"Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma","volume":"24","author":"Chapuy","year":"2013","journal-title":"Cancer Cell"},{"issue":"6264","key":"2026060911322616100_bib25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.aac7041","article-title":"Identification and characterization of essential genes in the human genome","volume":"350","author":"Wang","year":"2015","journal-title":"Science"},{"issue":"21","key":"2026060911322616100_bib26","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1182\/blood.2020010175","article-title":"OBF1 and Oct factors control the germinal center transcriptional program","volume":"137","author":"Song","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2026060911322616100_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.onc.1210637","article-title":"POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17","volume":"27","author":"Zhao","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"2026060911322616100_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10428194.2010.548535","article-title":"Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeutics","volume":"52","author":"Toman","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2026060911322616100_bib29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1182\/blood-2016-09-737536","article-title":"TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1","volume":"129","author":"Jahn","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2026060911322616100_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.06.006","article-title":"Targeting the mSWI\/SNF complex in POU2F-POU2AF transcription factor-driven malignancies","volume":"42","author":"He","year":"2024","journal-title":"Cancer Cell"},{"issue":"8","key":"2026060911322616100_bib31","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1073\/pnas.94.8.3639","article-title":"ELL2, a new member of an ELL family of RNA polymerase II elongation factors","volume":"94","author":"Shilatifard","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2026060911322616100_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol Cell"},{"issue":"9","key":"2026060911322616100_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrm3417","article-title":"The super elongation complex (SEC) family in transcriptional control","volume":"13","author":"Luo","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2026060911322616100_bib34","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.4049\/jimmunol.179.11.7663","article-title":"Increased phosphorylation of the carboxyl-terminal domain of RNA polymerase II and loading of polyadenylation and cotranscriptional factors contribute to regulation of the ig heavy chain mRNA in plasma cells","volume":"179","author":"Shell","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"2026060911322616100_bib35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.1786","article-title":"Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing","volume":"10","author":"Martincic","year":"2009","journal-title":"Nat Immunol"},{"issue":"40","key":"2026060911322616100_bib36","doi-asserted-by":"crossref","first-page":"16252","DOI":"10.1073\/pnas.1214414109","article-title":"Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells","volume":"109","author":"Benson","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026060911322616100_bib37","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.4049\/jimmunol.1401608","article-title":"Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response","volume":"193","author":"Park","year":"2014","journal-title":"J Immunol"},{"issue":"10","key":"2026060911322616100_bib38","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.4049\/jimmunol.1800557","article-title":"RNA splicing in the transition from B cells to antibody-secreting cells: the influences of ELL2, small nuclear RNA, and endoplasmic reticulum stress","volume":"201","author":"Nelson","year":"2018","journal-title":"J Immunol"},{"key":"2026060911322616100_bib39","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/ncomms8213","article-title":"Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma","volume":"6","author":"Swaminathan","year":"2015","journal-title":"Nat Commun"},{"issue":"11","key":"2026060911322616100_bib40","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.celrep.2017.08.062","article-title":"Genetic predisposition to multiple myeloma at 5q15 is mediated by an ELL2 enhancer polymorphism","volume":"20","author":"Li","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"2026060911322616100_bib41","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41467-018-04082-2","article-title":"The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression","volume":"9","author":"Ali","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"2026060911322616100_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/bloodadvances.2019000491","article-title":"A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry","volume":"4","author":"Du","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2026060911322616100_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41467-021-27666-x","article-title":"Functional dissection of inherited non-coding variation influencing multiple myeloma risk","volume":"13","author":"Ajore","year":"2022","journal-title":"Nat Commun"},{"issue":"7391","key":"2026060911322616100_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"7757","key":"2026060911322616100_bib45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"5","key":"2026060911322616100_bib46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s43018-023-00550-x","article-title":"Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias","volume":"4","author":"de Matos Simoes","year":"2023","journal-title":"Nat Cancer"},{"issue":"11","key":"2026060911322616100_bib47","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41556-021-00766-y","article-title":"Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma","volume":"23","author":"Frede","year":"2021","journal-title":"Nat Cell Biol"},{"issue":"2","key":"2026060911322616100_bib48","doi-asserted-by":"crossref","first-page":"e1752","DOI":"10.1002\/wrna.1752","article-title":"Integrating transcription and splicing into cell fate: transcription factors on the block","volume":"14","author":"Boumpas","year":"2023","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"3","key":"2026060911322616100_bib49","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3324\/haematol.2019.235424","article-title":"Differential RNA splicing as a potentially important driver mechanism in multiple myeloma","volume":"106","author":"Bauer","year":"2021","journal-title":"Haematologica"},{"issue":"12","key":"2026060911322616100_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41408-022-00759-6","article-title":"In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors","volume":"12","author":"Aktas Samur","year":"2022","journal-title":"Blood Cancer J"},{"issue":"1","key":"2026060911322616100_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13072-021-00425-4","article-title":"Revealing RCOR2 as a regulatory component of nuclear speckles","volume":"14","author":"Rivera","year":"2021","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"2026060911322616100_bib52","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41594-024-01465-6","article-title":"CTCF\/RAD21 organize the ground state of chromatin-nuclear speckle association","volume":"32","author":"Yu","year":"2025","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"2026060911322616100_bib53","doi-asserted-by":"crossref","first-page":"a000646","DOI":"10.1101\/cshperspect.a000646","article-title":"Nuclear speckles","volume":"3","author":"Spector","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8014","key":"2026060911322616100_bib54","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41586-024-07429-6","article-title":"Genome organization around nuclear speckles drives mRNA splicing efficiency","volume":"629","author":"Bhat","year":"2024","journal-title":"Nature"},{"issue":"9","key":"2026060911322616100_bib55","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nbt.4201","article-title":"Efficient proximity labeling in living cells and organisms with TurboID","volume":"36","author":"Branon","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"6","key":"2026060911322616100_bib56","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1038\/s44319-024-00152-3","article-title":"Conserved role of hnRNPL in alternative splicing of epigenetic modifiers enables B cell activation","volume":"25","author":"Subramani","year":"2024","journal-title":"EMBO Rep"},{"issue":"10","key":"2026060911322616100_bib57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"2026060911322616100_bib58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc1947","article-title":"Lineage dependency and lineage-survival oncogenes in human cancer","volume":"6","author":"Garraway","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2026060911322616100_bib59","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma","volume":"17","author":"Iida","year":"1997","journal-title":"Nat Genet"},{"issue":"7201","key":"2026060911322616100_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"2026060911322616100_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exphem.2022.07.300","article-title":"Lineage- and stage-specific oncogenicity of IRF4","volume":"114","author":"Amanda","year":"2022","journal-title":"Exp Hematol"},{"issue":"6","key":"2026060911322616100_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.05.007","article-title":"Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease","volume":"41","author":"Dang","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"2026060911322616100_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41408-023-00791-0","article-title":"Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics","volume":"13","author":"Ogiya","year":"2023","journal-title":"Blood Cancer J"},{"issue":"4","key":"2026060911322616100_bib64","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/11\/4049\/2524442\/blooda_adv-2025-018710-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/11\/4049\/2524442\/blooda_adv-2025-018710-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:32:38Z","timestamp":1781019158000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/11\/4049\/567540\/IL-6-driven-POU2AF1-and-ELL2-are-key-regulators-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018710","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,9]]},"published":{"date-parts":[[2026,6,2]]}}}